The following is a description of a study from one of the many researchers that our organization has funded.

Testing a Novel Way to Treat Arthritis

Hye-Jung Kim, PH.D.
Dana-Farber Cancer Institute
Boston, Massachusetts
CD8+ Treg suppression of collagen-induced arthritisAutoimmune diseases, including Rheumatoid Arthritis (RA), occur when the immune system mistakenly attacks the body’s own tissues. This complex system of cells and antibodies normally destroys “invaders” such as viruses and infections. Unfortunately, RA patients have immune cells and antibodies in their blood that attack their own tissues.

In this project, Dr. Kim evaluates the ability of a recently identified cell population, termed CD8+ regulatory T cells, to suppress or block RA progression. Using novel strategies, Dr. Kim will examine the potential therapeutic effects of this cell-based treatment to ameliorate or prevent RA.

You may return to the list of research that we have funded.
Translate »

Connect with ANRF Today!

Stay up -to-date with the latest arthritis news, stories and info.​

Make a Donation

Make a one-time or recurring donation and know that you are making a difference by funding cutting-edge arthritis research.

Skip to content